Study Description: Glaucoma is the second leading cause of blindness and affects approximately 70 million people worldwide. Our study is working towards identifying proteins that are elevated in the fluid inside the eyes of glaucoma patients compared to people without the disease. The study obtains samples of fluid from patients that are already having eye surgery that would otherwise be discarded. Studying these proteins will help our understanding of glaucoma, potentially leading to more accurate and earlier diagnosis of the disease.
Principal Investigator: Kathryn Bollinger
Eligibility Criteria: Patients will be recruited if they are undergoing an already-planned intraocular procedure in the GRU Eye Clinic.
Compensation: No, subjects will not be compensated.
If you don't see specific studies that interest you, please submit your contact information for future studies.